Mar. 7, 2017
BeiGene Ltd., the Guangzhou Development District and Guangzhou GET Technology Development Co., Ltd have entered into a definitive agreement to establish a state-of-the-art commercial-scale biologics manufacturing facility in Guangzhou, Guangdong Province. The joint venture, BeiGene Biologics Co., Ltd. will also provide funding for research and development of biologic drug candidates in China. Total direct investments are expected to amount to $330 million.